ATTENUATION OF METAPNEUMOVIRUS

Details for Australian Patent Application No. 2003240668 (hide)

Owner LOHMANN ANIMAL HEALTH GMBH AND CO. KG

Inventors NAYLOR, Clive, J.

Pub. Number AU-A-2003240668

PCT Number PCT/EP03/05187

PCT Pub. Number WO2003/097089

Priority 102 21 836.6 16.05.02 DE

Filing date 16 May 2003

Wipo publication date 2 December 2003

International Classifications

A61K 039/155 Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

C12N 015/85 Mutation or genetic engineering - for animal cells

C12N 007/04 Viruses, e.g. bacteriophages - Inactivation or attenuation

C07K 014/115 Peptides having more than 20 amino acids

C07K 014/11 Peptides having more than 20 amino acids

C12N 015/45 Mutation or genetic engineering

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 102 21 836.6 16.05.02 DE

29 January 2004 Application Open to Public Inspection

  Published as AU-A-2003240668

3 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240669-Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic

2003240667-Enzyme containing composition, process of producing said composition and its use